SE450251B - Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar - Google Patents

Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar

Info

Publication number
SE450251B
SE450251B SE8107022A SE8107022A SE450251B SE 450251 B SE450251 B SE 450251B SE 8107022 A SE8107022 A SE 8107022A SE 8107022 A SE8107022 A SE 8107022A SE 450251 B SE450251 B SE 450251B
Authority
SE
Sweden
Prior art keywords
compound according
xanthate
societies
cyclododecyl
alkyl
Prior art date
Application number
SE8107022A
Other languages
English (en)
Swedish (sv)
Other versions
SE8107022L (sv
Inventor
A Scherm
K Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of SE8107022L publication Critical patent/SE8107022L/xx
Publication of SE450251B publication Critical patent/SE450251B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02—Monothiocarbonic acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8107022A 1980-11-26 1981-11-25 Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar SE450251B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3044525 1980-11-26

Publications (2)

Publication Number Publication Date
SE8107022L SE8107022L (sv) 1982-05-27
SE450251B true SE450251B (sv) 1987-06-15

Family

ID=6117628

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107022A SE450251B (sv) 1980-11-26 1981-11-25 Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar

Country Status (24)

Country Link
US (2) US4602037A (xx)
JP (2) JPS5943944B2 (xx)
KR (1) KR870001238B1 (xx)
AR (1) AR230264A1 (xx)
AT (1) AT376202B (xx)
AU (1) AU549653B2 (xx)
BE (1) BE891245A (xx)
CA (1) CA1175047A (xx)
CH (1) CH651546A5 (xx)
DE (1) DE3146772C2 (xx)
DK (1) DK170068B1 (xx)
ES (1) ES507430A0 (xx)
FR (1) FR2494689B1 (xx)
GB (1) GB2091244B (xx)
GR (1) GR76308B (xx)
HU (1) HU187476B (xx)
IE (1) IE51944B1 (xx)
IT (1) IT1195297B (xx)
LU (1) LU83795A1 (xx)
NL (1) NL8105326A (xx)
PL (1) PL129383B1 (xx)
SE (1) SE450251B (xx)
SG (1) SG29285G (xx)
YU (1) YU42120B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법
DE3625948A1 (de) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
AT388499B (de) * 1985-08-02 1989-06-26 Merz & Co Gmbh & Co Verfahren zur herstellung einer antiviralen und antitumor-zusammensetzung, und deren verwendung
IT1213453B (it) * 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
EP0450492A1 (en) * 1990-04-06 1991-10-09 Tosoh Corporation Alkylxanthate, production thereof, photopolymerization initiator, and polymerization employing the same
WO1996014841A1 (en) * 1994-11-14 1996-05-23 Ct-Holding S.A. Antiviral and antitumor pharmaceutical compositions
DE10117728A1 (de) * 2001-04-09 2002-10-17 Biosphings Ag Pharmazeutische Formulierungen für Xanthogenate
DE10156617A1 (de) * 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
EP1391221A1 (en) * 2002-08-23 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
DE102005031265A1 (de) * 2005-07-05 2007-01-18 Sms Demag Ag Spreizbarer Haspeldorn
DE102006014390A1 (de) * 2006-03-29 2007-10-04 Biosphings Ag Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung
KR20100040905A (ko) * 2007-07-03 2010-04-21 루마비타 아게 트리시클로데칸-９-일-크산토게네이트의 입체이성질체
ES2727702T3 (es) * 2008-07-15 2019-10-18 Callery Llc Procedimiento para purificar sulfuros de dialquilo
US20100221809A1 (en) * 2008-12-23 2010-09-02 The Regents Of The University Of California Compositions and Methods for the Isolation of Biologically Active Proteins
CN114478339B (zh) * 2022-02-14 2023-12-08 中南大学 一种黄原酸盐类捕收剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1854525A (en) * 1929-11-11 1932-04-19 Shell Dev Tertiary xanthates
US1886587A (en) * 1930-01-09 1932-11-08 Hercules Powder Co Ltd Method of preparing xanthates of terpene alcohols
US2037718A (en) * 1932-11-09 1936-04-21 Du Pont Xanthates and method of making same
US2037717A (en) * 1932-11-09 1936-04-21 Du Pont Xanthates and method of making same
FR790353A (fr) * 1934-05-22 1935-11-20 Bataafsche Petroleum Préparation de xanthates
US2161584A (en) * 1936-08-01 1939-06-06 Socony Vacuum Oil Co Inc Petroleum lubricant composition
US2811432A (en) * 1953-07-17 1957-10-29 Monsanto Chemicals Herbicidal composition
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3864417A (en) * 1970-01-16 1975-02-04 Chevron Res Saturated hydrocarbon disproportionation at low temperatures
ZA715615B (en) * 1970-10-05 1972-04-26 American Cyanamid Co Manufacture of alkali metal xanthates
US3965137A (en) * 1974-05-02 1976-06-22 Stauffer Chemical Company Thiocyano xanthates
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법

Also Published As

Publication number Publication date
DE3146772C2 (de) 1994-09-22
DK170068B1 (da) 1995-05-15
YU278281A (en) 1984-02-29
FR2494689A1 (fr) 1982-05-28
JPS5943944B2 (ja) 1984-10-25
SE8107022L (sv) 1982-05-27
PL233966A1 (xx) 1982-07-05
GR76308B (xx) 1984-08-04
FR2494689B1 (fr) 1986-07-25
JPS57118557A (en) 1982-07-23
SG29285G (en) 1985-11-15
KR830007648A (ko) 1983-11-04
HU187476B (en) 1986-01-28
LU83795A1 (fr) 1983-09-01
IT8125291A0 (it) 1981-11-26
IE51944B1 (en) 1987-04-29
AU7792881A (en) 1982-07-08
KR870001238B1 (ko) 1987-06-26
US4981869A (en) 1991-01-01
AT376202B (de) 1984-10-25
DE3146772A1 (de) 1982-09-02
JPS6328410B2 (xx) 1988-06-08
GB2091244B (en) 1985-02-06
US4602037A (en) 1986-07-22
ES8400398A1 (es) 1983-11-01
ATA510181A (de) 1984-03-15
DK522081A (da) 1982-05-27
JPS591416A (ja) 1984-01-06
PL129383B1 (en) 1984-05-31
CA1175047A (en) 1984-09-25
NL8105326A (nl) 1982-06-16
IT1195297B (it) 1988-10-12
GB2091244A (en) 1982-07-28
IE812768L (en) 1982-05-26
AU549653B2 (en) 1986-02-06
BE891245A (fr) 1982-05-25
YU42120B (en) 1988-04-30
AR230264A1 (es) 1984-03-01
CH651546A5 (de) 1985-09-30
ES507430A0 (es) 1983-11-01

Similar Documents

Publication Publication Date Title
SE450251B (sv) Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar
WO1993016091A1 (de) Neue liponucleotide, deren herstellung sowie deren verwendung als antivirale arzneimittel
HU201672B (en) Process for producing pharmaceutical compositions comprising podophyllotoxin
US5356880A (en) Glycyrrhetinic acid derivatives
US6136857A (en) Methods for treating neoplasms with betaines
DE69906934T2 (de) Arzneizubereitungen
DE4014672A1 (de) Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen
DE3438585A1 (de) Neue sulfoxide, verfahren zu ihrer herstellung und ihre verwendung
KR930019212A (ko) 피소스티그민 유도체와 이의 용도 및 이를 함유한 제약적 조제물
US7915237B2 (en) Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom
CA1174978A (en) Xanthates
US5182273A (en) Spirocyclic n, o derivatives of cyclotriphosphazenes and their use in therapy
DE4003054A1 (de) Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten
DE2213028B2 (de) Dl-3-formylaminothiacyclopentan-2- on-, verfahren zu dessen herstellung und dl-3-formylamino-thiacyclopentan-2-on und andere acylderivate enthaltende pharmazeutische zusammensetzungen
US4288454A (en) Antiviral 1-adamantyl-3-(phenylsulfonyl)thioureas
DE69816835T2 (de) Inhibitoren der nuklearen lokalisierung von hiv
US5612319A (en) Postexposure prevention of HIV infection or seroconversion
CA1100877A (en) Antiviral agent
US20200079750A1 (en) Compound or salt thereof, antiviral agent, and pharmaceutical composition
EP0229501A1 (en) Thiadiazole antiviral agents
NL8202658A (nl) Esters van 2-thenoylmercaptopropionylglycine met gesubstitueerde hydroxybenzenen, werkwijzen ter bereiding ervan en farmaceutische samenstellingen, die deze esters bevatten.
AT392794B (de) Verfahren zur herstellung von neuen pharmazeutisch annehmbaren estern und salzen von 3'-azido-3'-desoxythymidin
RU2552422C2 (ru) Производные индол-3-карбоновой кислоты, обладающие противовирусной активностью
EP0558321A1 (en) Antivirally active N-cycloalkyl alkanol compounds
JPH0466575A (ja) ２―ニトロイミダゾール誘導体及びそれを含有する抗原虫剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8107022-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8107022-9

Format of ref document f/p: F